MedTrace Logo

Prospective Evaluation of the Quality of Life of Elderly Patients Undergoing Transfemoral Percutanous Aortic Valve Replacement (TAVI) for the Treatment of Severe Aortic Stenosis.

NCT05539937 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2024-04-24

No results posted yet for this study

Summary

In order to overcome the shortcomings of the assessment questionnaires currently available on the assessment of overall quality of life, the "Toronto Aortic Stenosis Quality of Life Questionnaire" (TASQ) was developed as a specific assessment tool for the impact of severe aortic stenosis in elderly patients, through 16 questions covering 5 domains: symptoms and physical limitations, emotional impact and expectations following TAVI, as well as social limitations incurred.

A better knowledge and understanding of the clinical outcomes and quality of life of elderly patients with severe symptomatic aortic stenosis at 12 months of follow-up of a TAVI procedure would further optimize the clinical decision-making process and patient selection who will benefit the most from this intervention in the long term.

Conditions

  • Quality of Life
  • Aortic Valve Replacement
  • Transfemoral Approach

Interventions

OTHER

Quality of life questionnaire

Before TAVI, 30 days, 6 months and twelve months after TAVI, patients will answer TASQ questionnaire,

Sponsors & Collaborators

  • Belledonne clinic

    collaborator UNKNOWN

  • European Clinical Trial Experts Network

    collaborator OTHER

  • Elsan

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-21
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05539937 on ClinicalTrials.gov